This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Dovato
  • /
  • An Efficacy, Safety, and Tolerability Study Compar...
Clinical trial

An Efficacy, Safety, and Tolerability Study Comparing Dolutegravir (DTG) Plus Lamivudine (3TC) With Dolutegravir Plus Tenofovir/Emtricitabine in Treatment naïve HIV Infected Subjects (Gemini 2)

Read time: 1 mins
Last updated:20th Apr 2020
Status: Active, not recruiting
Identifier: NCT02831764
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest